|
NCT01561508
|
2012-06-01 |
Effect of GABA Supplementation in the Progression of Type 1 Diabetes in Children
|
Phase 2
|
Withdrawn
|
|
NCT01536483
|
2012-02-01 |
Effects of Recto-colic Enemas of Butyrate on the Digestive Disorders of Very Low Birth Weight Preterms <1250 Grams
|
Phase 2/Phase 3
|
Recruiting
|
|
NCT01526876
|
2011-11-01 |
The Effect of Clevidipine on Intracranial Pressure and Cerebral Perfusion Pressure (CCP) in Brain Injured Patients
|
Phase 4
|
Withdrawn
|
|
NCT02173808
|
2011-05-01 |
A Phase I Study to Evaluate the PK and PD of a Single Injection of Levonorgestrel Butanoate for Female Contraception
|
Phase 1
|
Completed
|
|
NCT01042574
|
2010-05-01 |
The Efficacy and Safety of Cleviprex in Ventriculostomy Patients Requiring IV Antihypertensive Therapy
|
Phase 4
|
Recruiting
|
|
NCT00978822
|
2009-09-01 |
Safety and Efficacy Study of Clevidipine to Control Hypertension in Patients Admitted With Aneurysmal Subarachnoid Hemorrhage
|
Phase 2
|
Recruiting
|
|
NCT00917826
|
2008-09-01 |
Study of Arginine Butyrate and Ganciclovir/Valganciclovir in EBV(+) Lymphoid Malignancies
|
Phase 2
|
Terminated
|
|
NCT01567995
|
2008-02-01 |
Randomised, Double-blind, Placebo-controlled Study of Topical Clobetasone Butyrate 0.05% Cream in Subjects With Eczema for Two Weeks to Evaluate the Efficacy and Safety
|
Phase 3
|
Completed
|
|
NCT00693693
|
2006-11-01 |
Adherence to Topical Hydrocortisone 17-Butyrate 0.1% (Locoid®) Using Different Vehicles in Adults With Atopic Dermatitis
|
Phase 4
|
Active, Not Recruiting
|
|
NCT00800930
|
2005-01-01 |
Therapeutic Induction of Endogenous Antibiotics
|
Phase 2
|
Completed
|
|
NCT00801957
|
2003-03-01 |
Equivalence of the Response to Vaccination of Tacrolimus Ointment to a Steroid Ointment Regimen in Children With Atopic Dermatitis
|
Phase 2
|
Completed
|
|
NCT00006136
|
1999-03-01 |
Phase II Study of Arginine Butyrate With or Without Epoetin Alfa in Patients With Thalassemia Intermedia
|
Phase 2
|
Completed
|
|
NCT00004412
|
1997-09-01 |
Phase II Randomized Trial of Arginine Butyrate Plus Standard Local Therapy in Patients With Refractory Sickle Cell Ulcers
|
Phase 2
|
Recruiting
|
|
NCT00006340
|
1994-12-01 |
Ganciclovir Plus Arginine Butyrate in Treating Patients With Cancer or Lymphoproliferative Disorders Associated With the Epstein Barr Virus
|
Phase 1
|
Completed
|